Insulin Glargine
These highlights do not include all the information needed to use INSULIN GLARGINE-YFGN safely and effectively. See full prescribing information for INSULIN GLARGINE-YFGN. INSULIN GLARGINE-YFGN injection, for subcutaneous useInitial U.S. Approval: 2021This product is SEMGLEE (insulin glargine-yfgn). SEMGLEE (insulin glargine-yfgn) is interchangeable* with LANTUS (insulin glargine).
f8cf3733-952d-4cf1-99ff-5ec7b7247f75
HUMAN PRESCRIPTION DRUG LABEL
May 30, 2023
Mylan Specialty L.P.
DUNS: 194775557
Products 2
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
insulin glargine-yfgn
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (7)
insulin glargine-yfgn
Product Details
FDA regulatory identification and product classification information